{"slug":"eisai","name":"에자이","name_en":"Eisai","ticker":"4523.T","updated_at":"2026-07-11T10:20:54.728+00:00","canonical":"https://valuechain.wiki/eisai","kicker":"닛케이 225","kicker_en":"Nikkei 225","lead":"알츠하이머 치료제 레켐비로 알려진 일본의 대형 제약사다. 닛케이 225 구성종목. 밸류체인 관계·수치 데이터는 조사 전인 기본 노드로, AI 질문 수요가 관측되면 상세 노드로 승격된다.","lead_en":"Eisai is a major Japanese drugmaker known for the Alzheimer's treatment Leqembi. Nikkei 225 constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.","segments":{"parts":[{"name":"신경계(치매 치료제)"},{"name":"항암제"},{"name":"기타 의약품"}],"total":"약 ¥7,400억 (FY2024)"},"segments_en":{"parts":[{"name":"Neurology (dementia)"},{"name":"Oncology"},{"name":"Other pharmaceuticals"}],"total":"~¥740B (FY2024)"},"returns_yearly":{"2021":-22.9,"2022":42.2,"2023":-10.9,"2024":-32.2,"2025":-3.5,"2026":1.3},"return_asof":"2026-07-10","value_chain":{"leading":[],"benefiting":[],"analysis":null,"analysis_en":null,"analysis_asof":null},"edges":[]}